| Literature DB >> 29977265 |
Shehab M Abd El-Kader1, Fadwa M Al-Shreef2.
Abstract
BACKGROUND: Aging is characterized with immunosenescence associated with a hyper-inflammatory state, characterized by elevated circulating levels of pro-inflammatory mediators. Physical exercise is a potential strategy for improving the immune system dysfunction and chronic inflammation that accompanies aging. However, there is a need to differentiate between aerobic and resistance exercise training regarding human immune system and systemic inflammation among the elderly Saudi population.Entities:
Keywords: Immune function; aerobic exercise; aging; inflammatory cytokines; resistance exercise
Mesh:
Substances:
Year: 2018 PMID: 29977265 PMCID: PMC6016983 DOI: 10.4314/ahs.v18i1.16
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Figure (1)Subjects screening and recruitment CONSORT diagram.
Baseline characteristics of study participants.
| Characteristic | Group (A) | Group (B) | Significance |
| 66.43 ± 3.71 | 65. 96 ±3.42 | P>0.05 | |
| 71.15 ± 6.28 | 68.22 ± 7.53 | P>0.05 | |
| 1.67± 0.08 | 1.70 ± 0.07 | P>0.05 | |
| 24.13 ± 3.64 | 23.21 ± 3.12 | P>0.05 | |
| 131.61 ± 9.27 | 129.45±10.33 | P>0.05 | |
| 84.22 ± 4.31 | 83.31 ± 4.61 | P>0.05 | |
| 155.58 ± 10.25 | 152.91 ± 11.47 | P>0.05 |
BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HRmax: Maximum heart rate.
Mean value and significance of TNF-α, IL-6, IL-10, CD3 count, CD4 count, CD8 count and CD4/CD8 ratio in group (A) before and at the end of the study.
| Mean + SD | t-value | Significance | ||
| Pre | Post | |||
| 4.77 ± 1.62 | 3.21 ± 1.34 | 6.27 | P <0.05 | |
| 2.58 ± 0.93 | 1.76 ± 0.81 | 5.45 | P <0.05 | |
| 5.94 ± 1.25 | 7.63 ± 1.32 | 6.91 | P <0.05 | |
| 1.93 ± 0.87 | 1.31 ± 0.75 | 5.24 | P<0.05 | |
| 1.41 ± 0.92 | 1.10 ± 0.78 | 6.15 | P <0.05 | |
| 0.86 ± 0.33 | 0.57 ± 0.26 | 5.14 | P <0.05 | |
| 1.52 ± 0.86 | 1.15 ± 0.71 | 5.23 | P <0.05 | |
TNF-α: tumor necrosis factor — alpha; IL-6: Interleukin-6; IL-10: Interleukin-10;
indicates a significant difference between the two groups, P < 0.05.
Mean value and significance of TNF-α, IL-6, IL-10, CD3 count, CD4 count, CD8 count and CD4/CD8 ratio in group (B) before and at the end of the study.
| Mean + SD | t-value | Significance | ||
| Pre | Post | |||
| 4.56 ± 1.43 | 4.72 ± 1.57 | 0.94 | P>0.05 | |
| 2.40 ± 0.87 | 2.48 ± 0.92 | 0.76 | P>0.05 | |
| 6.36 ± 1.43 | 6.19 ± 1.36 | 1.12 | P>0.05 | |
| 1.82 ± 0.85 | 1.91 ± 0.86 | 0.82 | P>0.05 | |
| 1.35 ± 0.84 | 1.39 ± 0.87 | 0.65 | P>0.05 | |
| 0.81 ± 0.30 | 0.84 ± 0.33 | 0.71 | P>0.05 | |
| 1.48 ± 0.91 | 1.53 ± 0.86 | 0.88 | P>0.05 | |
TNF-α: tumor necrosis factor — alpha; IL-6: Interleukin-6; IL-10: Interleukin-10.
Mean value and significance of TNF-α, IL-6, IL-10, CD3 count, CD4 count, CD8 count and CD4/CD8 ratio in group (A) and group (B) at the end of the study.
| Mean + SD | t-value | Significance | ||
| Group (A) | Group (B) | |||
| 4.56 ± 1.43 | 4.72 ± 1.57 | 6.71 | P <0.05 | |
| 2.40 ± 0.87 | 2.48 ± 0.92 | 5.80 | P <0.05 | |
| 6.36 ± 1.43 | 6.19 ± 1.36 | 7.23 | P <0.05 | |
| 1.82 ± 0.85 | 1.91 ± 0.86 | 5.82 | P <0.05 | |
| 1.35 ± 0.84 | 1.39 ± 0.87 | 6.77 | P <0.05 | |
| 0.81 ± 0.30 | 0.84 ± 0.33 | 5.61 | P <0.05 | |
| 1.48 ± 0.91 | 1.53 ± 0.86 | 5.74 | P <0.05 | |
TNF-α: tumor necrosis factor — alpha; IL-6: Interleukin-6; IL-10: Interleukin-10;
indicates a significant difference between the two groups, P < 0.05.